Biological Material Analysis TRIZ Cases

Nanocarriers mimic beta-cell vesicles to deliver synthetic peptides into antigen presenting cells for hybrid peptide formation.

Fluorophores bind SARS-CoV-2 proteins in saliva to replace cumbersome nasal swabs and reduce testing time.

Segmenting detection with two antibodies binding distinct N-terminal epitopes raises measurement precision for low-concentration soluble GPC3.

A modified electrode uses electrochemical pretreatment to enhance protein adsorption capacity on a carbon nanomaterial surface.

Electrochemical biosensors replace optical tracking to quantify low-concentration exosomes, resolving the trade-off between isolation time and specificity.

Diluting gastrointestinal samples in a buffered aqueous extraction medium stabilizes protein extracts, resolving yield versus stability trade-offs.

Dual-chamber sensor measures osmotic pressure via glucose-permeable membrane to reject hydrostatic interference for accurate continuous monitoring.

Tracer-labelled antibodies visualize prostate tissue markers to differentiate cancer from benign conditions without invasive biopsies.

Modifying antibody Fc regions reduces autoimmune side effects while maintaining cancer treatment efficacy.

Modified amino acid sequences create artificial proteins that maintain stable binding across varying pH and temperature conditions.

Pdia4 antagonists diagnose cancer by detecting biomarkers, resolving the gap between anti-tumor activity and unknown molecular targets.

Magnetic beads capture analytes via capillary action on a hydrophobic membrane, eliminating centrifugation and reducing reagent consumption.

Recombinant Aspergillus fumigatus antigens enable selective activation and analysis of specific CD4+ T cells in clinical samples.

Cell-free refolding of MHC molecules replaces labor-intensive assays to screen large peptide sets while reducing material losses.

Antibodies targeting the conserved spike protein S2 domain achieve cross-reactive neutralizing activity against multiple coronavirus strains.

Fluorescent EphA2 labeling enables flow cytometry to isolate tumor-propagating cells, resolving the trade-off between isolation purity and procedure complexity.

A blood coagulation analysis method adds thrombomodulin and a heparin-like substance to evaluate protein C and S functions.

A test system permeabilizes pathogens and cells for fluorescent labeling and optical read-out using a magnifying unit.

Segmenting a sample via fluidic junctions prevents cross-activation of coagulation cascade pathways, enabling simultaneous PT and aPTT testing on one device.

Anti-TREML1 antibodies neutralize soluble TREML1, preventing CD11b binding and reversing immune suppression in inflammatory diseases.

Extracellular vesicle protein detection reveals Plasmodium vivax hypnozoites, enabling targeted radical cure without hemolytic anemia risks.

A capillary electrophoresis method binds analysis components to anionic compounds and removes aggregates before measurement.

Multiplexed microparticle assays detect SARS-CoV-2 antigens and antibodies simultaneously, reducing procedural complexity compared to sequential separate tests.

Segmentation and mediator principles allow specific capture antibodies to isolate wild-type Cry1Ab, resolving cross-reactivity interference in immunoassays.

High-density erythroid culture activates adhesion genes like ICAM-4 to boost terminal maturation rates while reducing required space.

A primary antibody binds residues 164-182 on CD155 to form a robust complex for tumor tissue analysis.

Modular gene circuits enhance biosensor sensitivity and dynamic range, resolving productivity trade-offs in non-model organism biomanufacturing.

A mid-infrared photonic biosensor detects biological analytes via waveguide absorption spectroscopy.

Lkb1 expression analysis determines cancer aggressiveness to resolve the trade-off between treatment efficacy and survival rates in non-small cell lung cancer.

Antibodies targeting IGSF8 reverse tumor-induced natural killer cell suppression, restoring cytotoxic activity against MHC-I null cancers.

Immobilized fucose-binding peptides capture specific glycoproteins to improve diagnostic sensitivity and specificity for hepatocellular carcinoma.

Pepsin digests vitamin D binding proteins under acidic conditions, eliminating slow extraction and radioactive tracers.

Polymethoxyflavones antagonize TAS2R receptors to block citrus bitterness without adding sweeteners or increasing caloric content.

A multiplex bead-based competitive inhibition assay quantifies individual carrier protein concentrations in multivalent vaccine compositions.

Segmented CDR regions recognize conserved WVN and FY motifs across genogroups, enabling broad detection without genotype-specific knowledge.

CLL-1 antibodies target cancer stem cells to reduce tumor growth while sparing normal hematopoietic stem cells.

Detergent-based extraction isolates platelet-associated analytes directly from plasma without centrifugation.

Human monoclonal antibodies bind influenza B hemagglutinin to neutralize viral infection, resolving vaccine adaptation needs and drug resistance issues.

A diagnostic device uses a soluble coating layer containing a blocking agent to suppress nonspecific binding on the sensor surface.

CabP mediates detection of low c-di-AMP levels, replacing complex LC-MS instrumentation with a cost-effective enzymatic readout.

Targeted CDR mutations reduce non-specific binding to cell surfaces, resolving the contradiction between detection accuracy and background noise.